Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Posttransfusion hepatitis. A prospective study].

C Villarreal-Urenda1, C Cano-Domínguez, V Zamalloa-Torres

  • 1Centro Médico La Raza, Instituto Mexicano del Seguro Social.

Gaceta Medica De Mexico
|March 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The molecular epidemiology of HIV type 1 of men in Mexico.

AIDS research and human retroviruses·2001
Same author

Safety and efficacy of Virend for topical treatment of genital and anal herpes simplex lesions in patients with AIDS.

Antiviral research·1997
Same author

Prevalence and risk factors for Chlamydia trachomatis infection in low-income rural and suburban populations of Mexico.

Sexually transmitted diseases·1996
Same author

[Risk of contamination with blood during obstetric-gynecologic surgery].

Ginecologia y obstetricia de Mexico·1996
Same author

Induction of humoral immune response to Salmonella typhimurium in mouse Peyer's patches.

Revista latinoamericana de microbiologia·1995
Same author

[The need, supply and demand for epidemiological research personnel in the Instituto Mexicano del Seguro Social].

Salud publica de Mexico·1993
Same journal

Evolution of children diagnosed with attention deficit hyperactivity disorder.

Gaceta medica de Mexico·2026
Same journal

Emergencies, disasters, and new challenges for the comprehensive training of healthcare professionals in universities.

Gaceta medica de Mexico·2026
Same journal

Reflections on the clinical application of pharmacogenetics in high-prevalence chronic diseases.

Gaceta medica de Mexico·2026
Same journal

Assessing of antibiotic resistance in the phage-plasmids of Klebsiella pneumoniae and its inhibitory compound.

Gaceta medica de Mexico·2026
Same journal

Prevalence of suspected non-alcoholic fatty liver disease in pediatric patients.

Gaceta medica de Mexico·2026
Same journal

Deep pancreatic enucleation: how to do it.

Gaceta medica de Mexico·2026
See all related articles

Post-transfusion hepatitis affects 33.3% of patients receiving blood products, with non-A, non-B hepatitis being the most common cause. Some cases progress to chronic hepatitis, highlighting transfusion risks.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Transfusion Medicine

Background:

  • Blood transfusions carry a risk of transmitting infectious agents.
  • Post-transfusion hepatitis (PTH) is a significant concern in transfusion medicine.
  • Identifying the causative agents and long-term outcomes of PTH is crucial for patient safety.

Purpose of the Study:

  • To investigate the incidence and etiological agents of post-transfusion hepatitis.
  • To determine the clinical presentation and outcomes of hepatitis following blood transfusions.
  • To assess the progression to chronic hepatitis in affected patients.

Main Methods:

  • A prospective study involving thirty patients who received blood or blood products.
  • Diagnosis of post-transfusion hepatitis based on clinical and laboratory findings.

Related Experiment Videos

  • Etiological classification of hepatitis (Hepatitis B vs. non-A, non-B hepatitis).
  • Percutaneous liver biopsy used to confirm chronic hepatitis.

    • Main Results:

    • Ten out of thirty patients (33.3%) were diagnosed with post-transfusion hepatitis.
    • The incidence rate was 15.75 cases per 1,000 units transfused.
    • Non-A, non-B hepatitis was diagnosed in 90% of cases, while 10% were Hepatitis B.
    • Two patients with non-A, non-B hepatitis developed chronic hepatitis, confirmed by liver biopsy.

    Conclusions:

    • Transfusion-associated hepatitis is a significant complication, predominantly caused by non-A, non-B hepatitis viruses.
    • A notable proportion of non-A, non-B hepatitis cases can lead to chronic liver disease.
    • Screening and prevention strategies for transfusion-transmitted hepatitis require continuous evaluation.